Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities PTGX - Protagonist Therapeutics, Inc.
-39.3 M
LAST VALUE
-57.33%
2 YEAR CAGR
-79.70%
5 YEAR CAGR
0.00%
10 YEAR CAGR